Abstract
In patients with stable coronary heart disease (CHD), we aimed to assess 1. the prognostic power of biomarkers reflecting haemodynamics, micronecrosis, inflammation, coagulation, lipids, neurohumoral activity, and renal function; 2. whether changes in concentrations of these biomarkers over 12 months affected subsequent CHD risk; and 3. whether pravastatin modified the change in biomarker concentrations and this influenced the risk of future events. In the LIPID study, 9014 patients were randomised to pravastatin 40 mg or placebo 3-36 months after an acute coronary syndrome. Eight biomarkers were measured at baseline (n=7863) and 12 months later (n=6434). During a median of 6.0 (IQR 5.5-6.5) years follow-up, 1100 CHD-related deaths and nonfatal myocardial infarctions occurred, 694 after biomarker measurement at 12 months. Baseline BNP, CRP, cystatin C, D-dimer, midregional pro-adrenomedullin, and sensitive troponin I predicted recurrent CHD events. In a multivariable model, sensitive troponin I, BNP, and cystatin C had the strongest associations with outcome (P<0.001 for trend). The strongest improvement in risk prediction was achieved by including sensitive troponin I (net reclassification improvement (NRI) 5.5%; P=0.003), BNP...Continue Reading
References
Apr 1, 1982·Radiology·J A Hanley, B J McNeil
Jan 20, 1999·Circulation·W KoenigM B Pepys
Mar 25, 2000·The New England Journal of Medicine·P M RidkerN Rifai
Jul 19, 2002·The New England Journal of Medicine·Alan S MaiselUNKNOWN Breathing Not Properly Multinational Study Investigators
Feb 13, 2004·The New England Journal of Medicine·Thomas J WangRamachandran S Vasan
Apr 6, 2005·Circulation·Ralph A H StewartUNKNOWN Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators
Jul 13, 2006·Circulation·Stefan BlankenbergUNKNOWN HOPE Study Investigators
Dec 22, 2006·The New England Journal of Medicine·Thomas J WangRamachandran S Vasan
Jun 15, 2007·Statistics in Medicine·Michael J PencinaRamachandran S Vasan
May 16, 2008·The New England Journal of Medicine·Björn ZetheliusJohan Arnlöv
Aug 28, 2009·The New England Journal of Medicine·Tobias ReichlinChristian Mueller
Nov 27, 2009·The New England Journal of Medicine·Torbjørn OmlandUNKNOWN Prevention of Events with Angiotensin Converting Enzyme Inhibition (PEACE) Trial Investigators
May 26, 2010·Circulation·Stefan BlankenbergUNKNOWN MORGAM Project
Sep 21, 2010·European Heart Journal·Renate B SchnabelStefan Blankenberg
Nov 17, 2010·JAMA : the Journal of the American Medical Association·Christopher R deFilippiStephen L Seliger
Jan 5, 2011·Statistics in Medicine·Michael J PencinaEwout W Steyerberg
Dec 20, 2011·Circulation·Marc S SabatineEugene Braunwald
Aug 22, 2012·Circulation·Thomas J WangJames L Januzzi
Feb 11, 2014·International Journal of Cardiology·Anne Funke-KaiserUNKNOWN LIPID Study Investigators
Apr 1, 2014·The New England Journal of Medicine·Harvey D WhiteLars Wallentin
Citations
Sep 9, 2016·Journal of the Royal Society, Interface·Etheresia PretoriusDouglas B Kell
Oct 16, 2016·Scientific Reports·Pengwei ZhuangJinao Duan
Apr 6, 2018·Lipids in Health and Disease·Elżbieta KimakJanusz Solski
Jun 28, 2017·Heart·Ralph A H StewartUNKNOWN LIPID Study Investigators
Sep 19, 2018·PloS One·Xiaojing QinYaping Wang
Jan 26, 2018·Circulation·John SimesUNKNOWN LIPID Study Investigators
Sep 15, 2018·Medicine·Andrzej CackoMarcin Grabowski
Oct 16, 2019·The Cochrane Database of Systematic Reviews·Claire SweeneyJoe Gallagher
Nov 7, 2016·Clinical Chemistry·Torbjørn Omland, Harvey D White
Sep 15, 2020·PloS One·Tsai-Chung LiCheng-Chieh Lin
Feb 22, 2017·Current Cardiology Reports·Anum Saeed, Christie M Ballantyne
May 22, 2019·European Journal of Clinical Investigation·Suzanne Schol-GelokTeun van Gelder
Dec 21, 2018·Circulation·Torbjørn Omland
Dec 19, 2019·Cardiovascular Diabetology·Yuen-Kwun WongHung-Fat Tse
Nov 24, 2020·Clinical Chemistry·Paul M HallerJohannes T Neumann
Jan 6, 2021·American Heart Journal·Maria TomasdottirZiad Hijazi
Jan 14, 2021·PLoS Medicine·Lars WallentinAgneta Siegbahn
Nov 2, 2020·BMC Nephrology·Chiu-Shong LiuCheng-Chieh Lin
Feb 22, 2021·Clinical Biochemistry·Paul Collinson
Jul 10, 2021·Frontiers in Cardiovascular Medicine·Xiaoxiao ZhaoHongbing Yan
Jul 10, 2021·Scientific Reports·Cheng-Chieh LinTsai-Chung Li